Abstract

Antiviral effectors such as Natural Killer (NK) cells have impaired functions in chronic hepatitis B (CHB) patients. The molecular mechanism responsible for this dysfunction remains poorly characterized. We show that decreased cytokine production capacity of peripheral NK cells from CHB patients was associated with reduced expression of NKp30 and CD16, and defective mTOR pathway activity. Transcriptome analysis of patients NK cells revealed an enrichment for transcripts expressed in exhausted T cells suggesting that NK cell dysfunction and T cell exhaustion employ common mechanisms. In particular, the transcription factor TOX and several of its targets were over-expressed in NK cells of CHB patients. This signature was predicted to be dependent on the calcium-associated transcription factor NFAT. Stimulation of the calcium-dependent pathway recapitulated features of NK cells from CHB patients. Thus, deregulated calcium signalling could be a central event in both T cell exhaustion and NK cell dysfunction occurring during chronic infections.

Data availability

Sequencing data have been deposited in GEO under accession codes GSE153946.

The following data sets were generated

Article and author information

Author details

  1. Marie Marotel

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Marine Villard

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Annabelle Drouillard

    International Center for Infectiology Research (CIRI), Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Issam Tout

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Laurie Besson

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Omran Allatif

    International Center for Infectiology Research (CIRI), Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Marine Pujol

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Yamila Rocca

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Michelle Ainouze

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Guillaume Roblot

    Immunology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Sébastien Viel

    International Center for Infectiology Research (CIRI), Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5085-443X
  12. Melissa Gomez

    Hepathology, CHU Limoges, Limoges, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Veronique Loustaud

    Hepathology, CHU Limoges, Limoges, France
    Competing interests
    The authors declare that no competing interests exist.
  14. Sophie Alain

    Hepathology, CHU Limoges, Limoges, France
    Competing interests
    The authors declare that no competing interests exist.
  15. David Durantel

    Cancerology, Inserm, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  16. Thierry Walzer

    International Center for Infectiology Research (CIRI), Lyon, France
    For correspondence
    thierry.walzer@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0857-8179
  17. Uzma Hasan

    Immunology, Inserm, Lyon, France
    For correspondence
    uzma.hasan@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
  18. Antoine Marçais

    International Center for Infectiology Research (CIRI), Lyon, France
    For correspondence
    antoine.marcais@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3591-6268

Funding

Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ECTZ22398)

  • Uzma Hasan

Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ECTZ11169)

  • Uzma Hasan

Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ECTZ19856)

  • Uzma Hasan

Agence Nationale de la Recherche (BaNK)

  • Antoine Marçais

Agence Nationale de la Recherche (SPHINKS)

  • Thierry Walzer

Association de Recherche sur le Cancer (Equipe labellisée)

  • Thierry Walzer

H2020 European Research Council (ERC-Stg 281025)

  • Thierry Walzer

La Ligue Nationale contre le Cancer (Graduate student fellowship)

  • Marie Marotel

La Ligue du Rhone (LNCC)

  • Uzma Hasan

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: All participants provided written informed consent in accordance with the procedure approved by the local ethics committee (Comité de Protection des Personnes, Centre Hospitalier Universitaire de Limoges, Limoges, France) and the Interventional research protocol involving human samples (Code promotor LiNKeB project: 87RI18-0021).

Copyright

© 2021, Marotel et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,448
    views
  • 360
    downloads
  • 25
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Marie Marotel
  2. Marine Villard
  3. Annabelle Drouillard
  4. Issam Tout
  5. Laurie Besson
  6. Omran Allatif
  7. Marine Pujol
  8. Yamila Rocca
  9. Michelle Ainouze
  10. Guillaume Roblot
  11. Sébastien Viel
  12. Melissa Gomez
  13. Veronique Loustaud
  14. Sophie Alain
  15. David Durantel
  16. Thierry Walzer
  17. Uzma Hasan
  18. Antoine Marçais
(2021)
Peripheral Natural Killer cells in chronic hepatitis B patients display multiple molecular features of T cell exhaustion
eLife 10:e60095.
https://doi.org/10.7554/eLife.60095

Share this article

https://doi.org/10.7554/eLife.60095

Further reading

    1. Immunology and Inflammation
    2. Microbiology and Infectious Disease
    Gregory T Walker, Araceli Perez-Lopez ... Manuela Raffatellu
    Research Article

    The chemokine CCL28 is highly expressed in mucosal tissues, but its role during infection is not well understood. Here we show that CCL28 promotes neutrophil accumulation in the gut of mice infected with Salmonella and in the lung of mice infected with Acinetobacter. Neutrophils isolated from the infected mucosa expressed the CCL28 receptors CCR3 and, to a lesser extent, CCR10, on their surface. The functional consequences of CCL28 deficiency varied between the two infections: Ccl28-/- mice were highly susceptible to Salmonella gut infection but highly resistant to otherwise lethal Acinetobacter lung infection. In vitro, unstimulated neutrophils harbored pre-formed intracellular CCR3 that was rapidly mobilized to the cell surface following phagocytosis or inflammatory stimuli. Moreover, CCL28 stimulation enhanced neutrophil antimicrobial activity, production of reactive oxygen species, and formation of extracellular traps, all processes largely dependent on CCR3. Consistent with the different outcomes in the two infection models, neutrophil stimulation with CCL28 boosted the killing of Salmonella but not Acinetobacter. CCL28 thus plays a critical role in the immune response to mucosal pathogens by increasing neutrophil accumulation and activation, which can enhance pathogen clearance but also exacerbate disease depending on the mucosal site and the infectious agent.

    1. Immunology and Inflammation
    2. Microbiology and Infectious Disease
    Daniel Spari, Annina Schmid ... Guido Beldi
    Research Article

    Sepsis causes millions of deaths per year worldwide and is a current global health priority declared by the WHO. Sepsis-related deaths are a result of dysregulated inflammatory immune responses indicating the need to develop strategies to target inflammation. An important mediator of inflammation is extracellular adenosine triphosphate (ATP) that is released by inflamed host cells and tissues, and also by bacteria in a strain-specific and growth-dependent manner. Here, we investigated the mechanisms by which bacteria release ATP. Using genetic mutant strains of Escherichia coli (E. coli), we demonstrate that ATP release is dependent on ATP synthase within the inner bacterial membrane. In addition, impaired integrity of the outer bacterial membrane notably contributes to ATP release and is associated with bacterial death. In a mouse model of abdominal sepsis, local effects of bacterial ATP were analyzed using a transformed E. coli bearing an arabinose-inducible periplasmic apyrase hydrolyzing ATP to be released. Abrogating bacterial ATP release shows that bacterial ATP suppresses local immune responses, resulting in reduced neutrophil counts and impaired survival. In addition, bacterial ATP has systemic effects via its transport in outer membrane vesicles (OMV). ATP-loaded OMV are quickly distributed throughout the body and upregulated expression of genes activating degranulation in neutrophils, potentially contributing to the exacerbation of sepsis severity. This study reveals mechanisms of bacterial ATP release and its local and systemic roles in sepsis pathogenesis.